KROS

KROS R&D Expenses

$75.86MTTM · USD

Period ending:

KROS FY R&D ExpensesUSD
KROS FY R&D Expenses2018-12-31: $10.11M2019-12-31: $17.38M2020-12-31: $33.86M2021-12-31: $55.14M2022-12-31: $87.27M2023-12-31: $135.26M2024-12-31: $173.63M2025-12-31: $129.64M$173.63M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

KROS r&d expenses history

Research and development spending. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Keros Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
129,643,000
173,629,000
135,258,000
87,265,000
55,143,000
33,860,000
17,379,000
10,111,000

Compare r&d expenses

All KROS financial metrics · KROS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.